Yankee; Thomas
Patent Applications and Registrations
Patent applications and USPTO patent grants for Yankee; Thomas.The latest application filed is for "engineered regulatory t cells".
- Yankee; Thomas - Overland Park KS
| Patent | Date |
|---|---|
| Eliminating MHC restriction from the T cell receptor as a strategy for immunotherapy Grant 11,299,552 - Yankee , et al. April 12, 2 | 2022-04-12 |
| Engineered Regulatory T Cells App 20220008474 - Seng; Amara ; et al. | 2022-01-13 |
| Engineered regulatory T cells Grant 11,160,832 - Seng , et al. November 2, 2 | 2021-11-02 |
| Engineered Regulatory T Cells App 20210008111 - Seng; Amara ; et al. | 2021-01-14 |
| Eliminating Mhc Restriction From The T Cell Receptor As A Strategy For Immunotherapy App 20190055318 - Yankee; Thomas ; et al. | 2019-02-21 |
| Treatment Or Prevention Of Surgery-induced Cachexia And/or Expression Of Myeloid-derived Suppressor Cells And Pro-inflammatory Cytokines App 20180021279 - Hamilton-Reeves; Jill ; et al. | 2018-01-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 